These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36184368)

  • 41. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
    Gilbert TR; Noar A; Blalock O; Polonsky WH
    Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
    [No Abstract]   [Full Text] [Related]  

  • 42. Continuous Blood Glucose Monitoring Increases Vigorous Physical Activity Levels and Is Associated With Reduced Hypoglycemia Avoidance Behavior In Youth With Type 1 Diabetes.
    Jabbour G; Bragazzi NL
    Front Endocrinol (Lausanne); 2021; 12():722123. PubMed ID: 34557162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing strengths of children with type 1 diabetes: Validation of the Diabetes Strengths and Resilience (DSTAR) measure for ages 9 to 13.
    Iturralde E; Hood KK; Weissberg-Benchell J; Anderson BJ; Hilliard ME
    Pediatr Diabetes; 2019 Nov; 20(7):1007-1015. PubMed ID: 31336011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Internal structure and psychometric properties of Diabetes Distress Scale for Type 1 Diabetes.
    Griva F; Thomakos P; Kepaptsoglou O; Ginieri-Coccossis M; Mitrakou Α; Zoupas C; Vaslamatzis G
    Psychiatriki; 2020; 31(4):302-309. PubMed ID: 33361060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year.
    Chamberlain JJ; Dopita D; Gilgen E; Neuman A
    J Diabetes Sci Technol; 2015 Sep; 10(2):383-8. PubMed ID: 26353781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth.
    Markowitz JT; Pratt K; Aggarwal J; Volkening LK; Laffel LM
    Diabetes Technol Ther; 2012 Jun; 14(6):523-6. PubMed ID: 22524590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life.
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Diabetes Technol Ther; 2015 Sep; 17(9):657-63. PubMed ID: 25923812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A profile of self-care behaviors in emerging adults with type 1 diabetes.
    Hendricks M; Monaghan M; Soutor S; Chen R; Holmes CS
    Diabetes Educ; 2013; 39(2):195-203. PubMed ID: 23396184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets.
    Tanenbaum ML; Hanes SJ; Miller KM; Naranjo D; Bensen R; Hood KK
    Diabetes Care; 2017 Feb; 40(2):181-187. PubMed ID: 27899489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spanish translation, adaptation and validation of the Hypoglycemia Fear Survey in adults with type 1 diabetes in the Community of Madrid.
    Tasende C; Rubio JA; Álvarez J
    Endocrinol Diabetes Nutr (Engl Ed); 2018 May; 65(5):287-296. PubMed ID: 29525369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fear of Hypoglycemia and Diabetes Distress: Expected Reduction by Glucose Prediction.
    Ehrmann D; Laviola L; Priesterroth LS; Hermanns N; Babion N; Glatzer T
    J Diabetes Sci Technol; 2024 Sep; 18(5):1027-1034. PubMed ID: 39158974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c.
    Kahkoska AR; Adair LA; Aiello AE; Burger KS; Buse JB; Crandell J; Maahs DM; Nguyen CT; Kosorok MR; Mayer-Davis EJ
    Pediatr Diabetes; 2019 Aug; 20(5):556-566. PubMed ID: 30972889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
    Oriot P; Hermans MP
    J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
    Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.
    Dovc K; Lanzinger S; Cardona-Hernandez R; Tauschmann M; Marigliano M; Cherubini V; Preikša R; Schierloh U; Clapin H; AlJaser F; Pelicand J; Shukla R; Biester T
    JAMA Netw Open; 2023 Feb; 6(2):e230077. PubMed ID: 36808243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older.
    Polonsky WH; Peters AL; Hessler D
    J Diabetes Sci Technol; 2016 Jul; 10(4):892-7. PubMed ID: 27022095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
    Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dimensionality and psychometric properties of the Greek version of the Τype 1 Diabetes Stigma Assessment Scale (DSAS-1-Gr).
    Benioudakis ES; Kalaitzaki A; Karlafti E; Kalpou MA; Savopoulos C; Didangelos T
    Psychiatriki; 2023 Dec; 34(4):279-288. PubMed ID: 36436216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re-examining a measure of diabetes-related burden in parents of young people with Type 1 diabetes: the Problem Areas in Diabetes Survey - Parent Revised version (PAID-PR).
    Markowitz JT; Volkening LK; Butler DA; Antisdel-Lomaglio J; Anderson BJ; Laffel LM
    Diabet Med; 2012 Apr; 29(4):526-30. PubMed ID: 21883443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.